Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity
Szerzők
Barsi, S.; Papp, H.; Valdeolivas, A.; Tóth, D.J.; Kuczmog, A.; Madai, M.; Hunyady, L.; Várnai, P.; Saez-Rodriguez, J.; Jakab, F. et al.